Analysis of bioactive oxysterols in newborn mouse brain by LC/MS

Journal of Lipid Research

Volumn 53, Issue 11, 2012, Pages 2469-2483

  Meljon, Anna ^a   Theofilopoulos, Spyridon ^b   Shackleton, Cedric H L ^c   Watson, Gordon L ^c   Javitt, Norman B ^d   Knölker, Hans Joachim ^e   Saini, Ratni ^e   Arenas, Ernest ^b   Wang, Yuqin ^a   Griffiths, William J ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

24S,25 epoxycholesterol; 24S hydroxycholesterol; Cholesterol; Derivatization; Desmosterol; Liver X receptor; Sterol

Indexed keywords

25 EPOXYCHOLESTEROL; 26 HYDROXYDESMOSTEROL; 7 ALPHA HYDROXYDESMOSTEROL; CHOLESTANOL; CHOLESTEROL DERIVATIVE; DESMOSTEROL; OXYSTEROL; PROGESTERONE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRAGMENTATION REACTION; LIPID ANALYSIS; LIPID BRAIN LEVEL; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANIMALS; ANIMALS, NEWBORN; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; DESMOSTEROL; HYDROXYCHOLESTEROLS; MASS SPECTROMETRY; MICE; STEROLS;

EID: 84867351590     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D028233     Document Type: Article

References (61)

1. Dietschy, J. M., and S. D. Turley. 2004. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45: 1375-1397. (Pubitemid 39022664)
2. Björkhem, I., and S. Meaney. 2004. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24: 806-815.
3. Dietschy, J. M., and S. D. Turley. 2001. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12: 105-112. (Pubitemid 32242918)
4. Tint, G. S., H. Yu, Q. Shang, G. Xu, and S. B. Patel. 2006. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J. Lipid Res. 47: 1535-1541. (Pubitemid 44079908)
5. Wang, Y., K. M. Sousa, K. Bodin, S. Theofilopoulos, P. Sacchetti, M. Hornshaw, G. Woffendin, K. Karu, J. Sjövall, E. Arenas, et al. 2009. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. Mol. Biosyst. 5: 529-541.
6. Xie, C., E. G. Lund, S. D. Turley, D. W. Russell, and J. M. Dietschy. 2003. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44: 1780-1789. (Pubitemid 37185890)
7. Lütjohann, D., O. Breuer, G. Ahlborg, I. Nennesmo, A. Siden, U. Diczfalusy, and I. Björkhem. 1996. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA. 93: 9799-9804.
8. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 96: 7238-7243. (Pubitemid 29299645)
9. Ohyama, Y., S. Meaney, M. Heverin, L. Ekström, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al. 2006. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J. Biol. Chem. 281: 3810-3820. (Pubitemid 43847805)
10. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA. 96: 266-271. (Pubitemid 29036088)
11. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, et al. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140. (Pubitemid 27066798)
12. Mellon, S. H., and L. D. Griffin. 2002. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13: 35-43. (Pubitemid 36734014)
13. Yao, Z. X., R. C. Brown, G. Teper, J. Greeson, and V. Papadopoulos. 2002. 22R-hydroxycholesterol protects neuronal cells from beta-amyloid-induced cytotoxicity by binding to beta-amyloid peptide. J. Neurochem. 83: 1110-1119. (Pubitemid 35397121)
14. Koldamova, R. P., I. M. Lefterov, M. D. Ikonomovic, J. Skoko, P. I. Lefterov, B. A. Isanski, S. T. DeKosky, and J. S. Lazo. 2003. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278: 13244-13256. (Pubitemid 36800094)
15. Radhakrishnan, A., Y. Ikeda, H. J. Kwon, M. S. Brown, and J. L. Goldstein. 2007. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA. 104: 6511-6518. (Pubitemid 47175533)
16. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131. (Pubitemid 34496588)
17. Brown, M. S., and J. L. Goldstein. 2009. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 50 (Suppl): S15-S27.
18. Wong, J., C. M. Quinn, I. C. Gelissen, and A. J. Brown. 2008. Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J. Biol. Chem. 283: 700-707.
19. Liere, P., A. Pianos, B. Eychenne, A. Cambourg, K. Bodin, W. Griffiths, M. Schumacher, E. E. Baulieu, and J. Sjövall. 2009. Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J. Lipid Res. 50: 2430-2444.
20. Schroepfer, G. J., Jr. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80: 361-554.
21. Heverin, M., N. Bogdanovic, D. Lütjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Björkhem. 2004. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45: 186-193. (Pubitemid 38180529)
22. Karu, K., M. Hornshaw, G. Woffendin, K. Bodin, M. Hamberg, G. Alvelius, J. Sjövall, J. Turton, Y. Wang, and W. J. Griffiths. 2007. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J. Lipid Res. 48: 976-987. (Pubitemid 46562412)
23. Liu, S., J. Sjövall, and W. J. Griffiths. 2003. Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography-electrospray mass spectrometry. Anal. Chem. 75: 5835-5846.
24. McDonald, J. G., B. M. Thompson, E. C. McCrum, and D. W. Russell. 2007. Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry. Methods Enzymol. 432: 145-170.
25. Griffiths, W. J., and Y. Wang. 2011. Analysis of oxysterol metabolomes. Biochim. Biophys. Acta. 1811: 784-799.
26. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
27. Honda, A., K. Yamashita, T. Hara, T. Ikegami, T. Miyazaki, M. Shirai, G. Xu, M. Numazawa, and Y. Matsuzaki. 2009. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J. Lipid Res. 50: 350-357.
28. Karu, K., J. Turton, Y. Wang, and W. J. Griffiths. 2011. Nano-liquid chromatography-tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation. Chem. Phys. Lipids. 164: 411-424.
29. Griffiths, W. J., Y. Wang, G. Alvelius, S. Liu, K. Bodin, and J. Sjövall. 2006. Analysis of oxysterols by electrospray tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 17: 341-362. (Pubitemid 43290194)
30. Pikuleva, I., and N. B. Javitt. 2003. Novel sterols synthesized via the CYP27A1 metabolic pathway. Arch. Biochem. Biophys. 420: 35-39. (Pubitemid 37393371)
31. Marcos, J., C. H. Shackleton, M. M. Buddhikot, F. D. Porter, and G. L. Watson. 2007. Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome). Steroids. 72: 802-808. (Pubitemid 47320712)
32. Ogundare, M., S. Theofilopoulos, A. Lockhart, L. J. Hall, E. Arenas, J. Sjövall, A. G. Brenton, Y. Wang, and W. J. Griffiths. 2010. Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J. Biol. Chem. 285: 4666-4679.
33. MacLachlan, J., A. T. Wotherspoon, R. O. Ansell, and C. J. Brooks. 2000. Cholesterol oxidase: sources, physical properties and analytical applications. J. Steroid Biochem. Mol. Biol. 72: 169-195. (Pubitemid 30261523)
34. Shackleton, C. H., H. Chuang, J. Kim, X. de la Torre, and J. Segura. 1997. Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids. 62: 523-529. (Pubitemid 27319201)
35. Lütjohann, D., A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, and T. A. Bayer. 2002. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 43: 1078-1085.
36. Griffiths, W. J., and Y. Wang. 2009. Sterol lipidomics in health and disease: methodologies and applications. Eur. J. Lipid Sci. Technol. 111: 14-38.
37. Lütjohann, D., I. Björkhem, S. Locatelli, C. Dame, J. Schmolling, K. von Bergmann, and H. Fahnenstich. 2001. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. Acta Paediatr. 90: 652-657.
38. Lund, E. G., T. A. Kerr, J. Sakai, W. P. Li, and D. W. Russell. 1998. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273: 34316-34327. (Pubitemid 29008909)
39. Mast, N., R. Norcross, U. Andersson, M. Shou, K. Nakayama, I. Björkhem, and I. A. Pikuleva. 2003. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry. 42: 14284-14292. (Pubitemid 37499426)
40. Cali, J. J., and D. W. Russell. 1991. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J. Biol. Chem. 266: 7774-7778. (Pubitemid 21906433)
41. Repa, J. J., E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley. 2000. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 275: 39685-39692. (Pubitemid 32058997)
42. Lund, E., I. Björkhem, C. Furster, and K. Wikvall. 1993. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta. 1166: 177-182.
43. Lund, E. G., C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell. 2003. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278: 22980-22988. (Pubitemid 36830363)
44. Compagnone, N. A., A. Bulfone, J. L. Rubenstein, and S. H. Mellon. 1995. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology. 136: 2689-2696.
45. Jelinek, D. F., S. Andersson, C. A. Slaughter, and D. W. Russell. 1990. Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265: 8190-8197.
46. Murphy, R. C., and K. M. Johnson. 2008. Cholesterol, reactive oxygen species, and the formation of biologically active mediators. J. Biol. Chem. 283: 15521-15525.
47. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, Jr., R. C. Murphy, C. R. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46: 839-861.
48. Byon, C. Y., and M. Gut. 1980. Steric considerations regarding the biodegradation of cholesterol to pregnenolone. Exclusion of (22S)-22- hydroxycholesterol and 22-ketocholesterol as intermediates. Biochem. Biophys. Res. Commun. 94: 549-552. (Pubitemid 10006070)
49. Kautsky, G. J., C. Bouboulis, R. Becker, and C. King. 1958. Synthesis and metabolism of 22-ketocholesterol-23-C14. J. Biol. Chem. 233: 1340-1342.
50. Karlaganis, G., and J. Sjövall. 1984. Formation and metabolism of bile alcohols in man. Hepatology. 4: 966-973.
51. Shefer, S., F. W. Cheng, B. Dayal, S. Hauser, G. S. Tint, G. Salen, and E. H. Mosbach. 1976. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat. J. Clin. Invest. 57: 897-903.
52. Heverin, M., S. Meaney, A. Brafman, M. Shafir, M. Olin, M. Shafaati, S. von Bahr, L. Larsson, A. Lövgren-Sandblom, U. Diczfalusy, et al. 2007. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler. Thromb. Vasc. Biol. 27: 2191-2197. (Pubitemid 350287249)
53. McDonald, J. G., D. D. Smith, A. R. Stiles, and D. W. Russell. 2012. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J. Lipid Res. 53: 1399-1409.
54. Quan, G., C. Xie, J. M. Dietschy, and S. D. Turley. 2003. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. Dev. Brain Res. 146: 87-98. (Pubitemid 37474113)
55. Rodríguez-Acebes, S., P. de la Cueva, C. Fernandez-Hernando, A. J. Ferruelo, M. A. Lasuncion, R. B. Rawson, J. Martinez-Botas, and D. Gomez-Coronado. 2009. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase- deficient cell line. Biochem. J. 420: 305-315.
56. Yang, C., J. G. McDonald, A. Patel, Y. Zhang, M. Umetani, F. Xu, E. J. Westover, D. F. Covey, D. J. Mangelsdorf, J. C. Cohen, et al. 2006. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J. Biol. Chem. 281: 27816-27826. (Pubitemid 44414494)
57. Roberg-Larsen, H., M. F. Strand, A. Grimsmo, P. A. Olsen, J. L. Dembinski, F. Rise, E. Lundanes, T. Greibrokk, S. Krauss, and S. R. Wilson. 2012. High sensitivity measurements of active oxysterols with automated filtration/filter backflush-solid phase extraction-liquid chromatography-mass spectrometry. J. Chromatogr. A. 1255: 291-297.
58. Sacchetti, P., K. M. Sousa, A. C. Hall, I. Liste, K. R. Steffensen, S. Theofilopoulos, C. L. Parish, C. Hazenberg, L. A. Richter, O. Hovatta, et al. 2009. Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell. 5: 409-419.
59. Wang, L., G. U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J. A. Gustafsson. 2002. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. USA. 99: 13878-13883. (Pubitemid 35215474)
60. Schumacher, M., P. Liere, Y. Akwa, K. Rajkowski, W. Griffiths, K. Bodin, J. Sjövall, and E. E. Baulieu. 2008. Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem. Int. 52: 522-540.
61. Saijo, K., J. G. Collier, A. C. Li, J. A. Katzenellenbogen, and C. K. Glass. 2011. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell. 145: 584-595.